LVW Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $489K | Buy |
|
|||||
|
2024
Q4 | $565K | Sell |
|
|||||
|
2024
Q3 | $683K | Buy |
|
|||||
|
2024
Q2 | $641K | Buy |
|
|||||
|
2024
Q1 | $768K | Sell |
|
|||||
|
2023
Q4 | $685K | Sell |
|
|||||
|
2023
Q3 | $577K | Sell |
|
|||||
|
2023
Q2 | $675K | Sell |
|
|||||
|
2023
Q1 | $654K | Sell |
|
|||||
|
2022
Q4 | $727K | Sell |
|
|||||
|
2022
Q3 | $706K | Buy |
|
|||||
|
2022
Q2 | $748K | Buy |
|
|||||
|
2022
Q1 | $942K | Sell |
|
|||||
|
2021
Q4 | $1.32M | Sell |
|
|||||
|
2021
Q3 | $1.47M | Buy |
|
|||||
|
2021
Q2 | $1.3M | Sell |
|
|||||
|
2021
Q1 | $1.13M | Buy |
|
|||||
|
2020
Q4 | $695K | Buy |
|
|||||
|
2020
Q3 | $606K | Buy |
|
|||||
|
2020
Q2 | $319K | Buy |
|